Clinical Trial

Insulin Resistance as a Predictor of Pulsed Field Ablation Success in Atrial Fibrillation (HOMA-PULSE)

NCT ID
NCT07551947
Status
Enrolling by invitation
Study Type
Observational
Lead Sponsor
Nemocnice AGEL Trinec-Podlesi a.s.
Enrollment
120 participants
Start
Apr 2026
Estimated Completion
Dec 2028

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.